Actinium Pharmaceuticals, Inc logo
VerifiedBiotechnology Research· Founded 2000

Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT

7-day free trial · no credit card

HeadquartersNew York, United StatesEmployees56(11 to 50)Annual revenue$1M to <$10MFounded year2000Websiteactiniumpharma.comLinkedIn profileLinkedIn

Verified contacts

42

available on Kipplo

LinkedIn employees

56

11 to 50 range

Open roles

no listings

Distinct roles

38

indexed titles

Tech stack

4

tools in use

Monthly traffic

1.5K

organic / mo

Sign up free to see all 42 verified contacts at Actinium Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

42 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Actinium Pharmaceuticals, Inc

38 distinct titles indexed · top 10 shown.

  • 1()
  • 1, -
  • 1accounts payable specialist
  • 1associate director preclinical toxicology
  • 1associate director, radiopharmaceutical product development
  • 1associate scientist
  • 1board member
  • 1business development manager
  • 1chief business officer
  • 1chief financial officer
  • +28more titles

Sign up to unlock all 42 contacts at Actinium Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 42 verified contacts at Actinium Pharmaceuticals, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Actinium Pharmaceuticals, Inc | Kipplo Discover